← back to search

Odile Launay

Assistance Publique – Hôpitaux de Paris ·
🔎 Find collaborators in Epidemiology · Health →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Epidemiology · Health
Research interest
Research interests include Vaccine Coverage and Hesitancy, Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, and Respiratory viral infections research.
h-index
59
citations
13,901
works
572
NIH funding
primary concept
Medicine
email

Recent publications

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination
JAMA Network Open 2024cited by 30position: middledoi
Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort
Metabolism 2023cited by 24position: middledoi
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort
Journal of Antimicrobial Chemotherapy 2023cited by 21position: middledoi
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies
Human Vaccines & Immunotherapeutics 2022cited by 56position: middledoi
Attitudes towards monkeypox vaccination among healthcare workers in France and Belgium: an element of complacency?
Journal of Hospital Infection 2022cited by 25position: middledoi
One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort
Clinical Microbiology and Infection 2022cited by 24position: lastdoi
A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox
Nature Medicine 2022cited by 21position: lastdoi
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
The Lancet Infectious Diseases 2022cited by 20position: middledoi
Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey
Human Vaccines & Immunotherapeutics 2022cited by 13position: middledoi
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
The Lancet Infectious Diseases 2021cited by 343position: middledoi
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
Clinical Microbiology and Infection 2021cited by 107position: middledoi
Microbiota-based markers predictive of development of Clostridioides difficile infection
Nature Communications 2021cited by 87position: lastdoi
A French cohort for assessing COVID-19 vaccine responses in specific populations
Nature Medicine 2021cited by 34position: lastdoi
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics
Nature Communications 2021cited by 33position: lastdoi
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017–2019: an observational study
European Respiratory Journal 2021cited by 24position: middledoi
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
The Lancet Infectious Diseases 2020cited by 75position: middledoi
Complicated hospitalization due to influenza: results from the Global Hospital Influenza Network for the 2017–2018 season
BMC Infectious Diseases 2020cited by 58position: middledoi
Characteristics of human metapneumovirus infection in adults hospitalized for community-acquired influenza-like illness in France, 2012–2018: a retrospective observational study
Clinical Microbiology and Infection 2020cited by 44position: lastdoi
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study
Infection 2020cited by 36position: middledoi
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
PLoS Pathogens 2020cited by 14position: middledoi
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
The Lancet Infectious Diseases 2019cited by 36position: middledoi
Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?
PLoS ONE 2019cited by 19position: middledoi
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial
The Lancet 2018cited by 95position: middledoi
Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study
Digestive and Liver Disease 2018cited by 42position: lastdoi
Vaccines for healthcare-associated infections: present, future, and expectations
Expert Review of Vaccines 2018cited by 28position: middledoi
Prognostic Factors in Syphilitic Uveitis
Ophthalmology 2017cited by 52position: middledoi
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season
Eurosurveillance 2017cited by 35position: middledoi
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France
Clinical Microbiology and Infection 2016cited by 109position: middledoi
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study
Journal of Clinical Virology 2016cited by 70position: lastdoi
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study
Journal of Crohn s and Colitis 2015cited by 54position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Paul Loubet · Centre de Recherche Épidémiologie et Statistique8 papers (2016–2023)Xavier Duval · Johns Hopkins Hospital6 papers (2013–2021) · 6 papers (2014–2021)Fabrice Carrat · Inserm5 papers (2015–2021)Philippe Vanhems · Université Claude Bernard Lyon 15 papers (2016–2021)Bruno Lina · Centre International de Recherche en Infectiologie4 papers (2016–2021) · 4 papers (2016–2021)Pierre Tattevin · Montreal Heart Institute3 papers (2016–2023)Élisabeth Botelho-Nevers · Johns Hopkins Hospital3 papers (2018–2022) · 3 papers (2020–2021)Éric Tartour · Centre d'Immunologie et des Maladies Infectieuses3 papers (2015–2022) · 3 papers (2020–2021)Sélilah Amour · Université Claude Bernard Lyon 13 papers (2020–2021)Xavier de Lamballerie · Inserm3 papers (2021–2023)S. Jouneau · Université Claude Bernard Lyon 12 papers (2016–2020) · 2 papers (2013–2017)Corinne Merle · World Health Organization2 papers (2016–2021)Marc Rondy · National Institute for Public Health and the Environment2 papers (2013–2017)Fabrice Lainé · Nutrition, métabolismes et cancer2 papers (2020–2021)Élie Azria · Université Claude Bernard Lyon 12 papers (2013–2014)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Epidemiology · Health →